Researchers and doctors from UCLA Health will present 23 studies covering lung cancer, pediatric cancer, survivorship, and healthcare equity,...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - Times of India - Business - 25/Sep 16:03
AstraZeneca gets nod to launch cancer drug
AstraZeneca Pharma India has received approval from the Central Drugs Standard Control Organisation to import Durvalumab for sale and distribution. The drug, combined with chemotherapy, treats resectable non-small cell lung cancer without specific genetic mutations. Lung cancer remains a significant cause of mortality in India, highlighting the importance of this development.
Articles similaires
InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP─248 for acute myeloid leukaemia
pharmabiz.com - 20/Sep 16:36
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the...
Non Small Cell Lung Cancer Pipeline Insights, Treatment Drugs, Emerging Therapies and Companies 2024
mountaintoday.in - 17/Sep 19:33
DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) Pipeline Insight, 2024,” report provides comprehensive insights about...
Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
drugs.com - 19/Sep 15:09
THURSDAY, Sept. 19, 2024 -- For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer...
AZN's Tagrisso Gets FDA Nod for Expanded Use in NSCLC
zacks.com - 26/Sep 16:08
The FDA approves AstraZeneca's Tagrisso for treating unresectable, stage III EGFR-mutated non-small cell lung cancer.
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer
drugs.com - 18/Sep 15:09
WEDNESDAY, Sept. 18, 2024 -- Neoadjuvant platinum-based chemotherapy improves structure preservation (SP) for patients with T3, T4a, and selected T4b...
Imugene gets crucial FDA nod for bile tract cancer drug
thewest.com.au - 18/Sep 06:47
Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its recent metastatic advanced...
Imugene gets crucial FDA nod for bile tract cancer drug
thewest.com.au - 18/Sep 06:47
Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its recent metastatic advanced...
Honey bee venom can kill cancer cell membranes
times of india - 20/Sep 04:57
Researchers from the Harry Perkins Institute and the University of Western Australia have discovered that honeybee venom can kill cancer cells. The...
EMA's human medicines committee recommends approval of Henlius' Hansizhuang to treat extensive─stage small cell lung cancer
pharmabiz.com - 23/Sep 11:16
Shanghai Henlius Biotech, Inc., a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the...
Les derniers communiqués
-
Aucun élément